Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain 4Prostatic Neoplasms 3Carcinoma, Hepatocellular 3Pain, Postoperative 2Lung Neoplasms 2Inflammation 2Stomach Neoplasms 1Postoperative Nausea and Vomiting 1Pancreatic Neoplasms 1Neuroma, Acoustic 1Neoplasms 1Melanoma 1Liver Neoplasms 1Liver Diseases 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Chronic Pain 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1

Interventions

Radiosurgery 4Cochlear Implants 4Bevacizumab 4Gentamicins 3Everolimus 3Lapatinib 2tozuleristide 1neratinib 1icotinib 1gallium Ga 68 dotatate 1brigatinib 1Triamcinolone Acetonide 1Temozolomide 1Sufentanil 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Mn-PyC3A 1Methylprednisolone 1Magnetic Resonance Spectroscopy 1Losartan 1Head Movements 1HDAC-42 1Fluoresceins 1Fluorescein 1Endostatins 1Endoscopes 1Docosahexaenoic Acids 1Decision Support Techniques 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuroma, Acoustic × Sufentanil × Clear all
NCT07479446 2026-05-22

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Xuanwu Hospital, Beijing

Phase NA Recruiting
174 enrolled
CNS

Neuroma, Acoustic, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡